“The eubiotics market in feed has been growing rapidly in the recent years and is projected to reach a market size at USD 7.05 billion by 2020. The market is primarily driven by the growing customer attention towards superior quality feed grades, ban on antibiotics used as growth promoters in the North American and European regions, and for feed supplementation to improve nutrient utilization and nutrient supply to the animals. The consumption of eubiotics is increasing significantly due to various government regulations being adopted to improve animal health.
Europe held the largest share of the eubiotics market in 2014. Currently, the eubiotics market is concentrated more in developed and developing countries, such as U.S., China, India, Japan, Australia, along with European countries. The growth is mainly due to the global increase in meat consumption and rise in concern regarding its quality and safety. The market for probiotics is projected to grow at the highest CAGR of 7.6% during the period from 2015 to 2020. The probiotics segment also accounted for the largest share of 65.47% in 2014, and is projected to be valued at USD 4.69 billion by 2020.
The eubiotics market is highly competitive with a large number of global market players. This report highlights the growth strategies adopted by the major market players between 2010 and 2015. Key industry players invest extensively in research and development initiatives to expand their product portfolios. Continuous investments in new product development, launches, and expansions have expanded the scope of the industry.
The global market is marked with intense competition due to the presence of a large number of big and small firms. New product developments, mergers & acquisitions, and expansions are the key strategies adopted by market players to ensure their growth. The market is dominated by players such as the Chr. Hansen (Denmark), Cargill Incorporated (U.S.) and ADDCON (Germany), BASF SE (Germany), Kemin Industries Inc. (U.S.), and Behn Meyer (Singapore).
Global eubiotics market is segmented into type, livestock, and region. The said market was valued at USD 4.62 billion in 2014 and is projected to grow at a CAGR of 7.4% from 2015 to 2020.
“
